By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EyeGate Pharma 

100 Beaver Street

Waltham  Massachusetts  02453-8425  U.S.A.
Phone: 781-788-8869 Fax:


Medical Device

Company News
EyeGate Pharma Reports Second Quarter 2017 Financial Results And Provides Business Update 8/7/2017 12:03:58 PM
EyeGate Pharma Pharma Enrolls First Patient In Phase IIb Clinical Study Of EGP-437 For Cataract Surgery 8/1/2017 11:54:53 AM
EyeGate Pharma Announces $10 Million Public Offering 6/9/2017 10:02:22 AM
EyeGate Pharma Receives Milestone Payment From Valeant (VRX) For EGP-437 For Post-Operative Ocular Inflammation And Pain In Ocular Surgery Patients 5/22/2017 6:35:04 AM
EyeGate Pharma Reports First Quarter 2017 Financial Results And Provides Business Update 5/8/2017 10:09:04 AM
EyeGate Pharma Submits Investigational Device Exemption (IDE) Filing For Second Pilot Study Of Ocular Bandage Gel 5/4/2017 10:59:44 AM
EyeGate Pharma Strengthens Scientific Advisory Board With Appointments Of Daniel S. Durrie, M.D. And Randall J. Olson, M.D. 3/13/2017 9:03:21 AM
EyeGate Pharma Reports Full-Year 2016 Financial Results And Provides Business Update 2/24/2017 8:18:01 AM
Valeant (VRX) And EyeGate Pharma Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients 2/21/2017 6:28:55 AM
EyeGate Pharma Announces Executive Promotions 2/7/2017 11:13:58 AM